natgillin/translations-raw huggingface dataset:
The active substance in Hemangiol, propranolol, belongs to a group of medicines called beta-blockers, which have been widely used to treat several conditions in adults, including diseases of the heart and high blood pressure. 
Zdravilna učinkovina v zdravilu Hemangiol, propranolol, spada v skupino zdravil, imenovanih zaviralci receptorjev beta, ki se pogosto uporabljajo za zdravljenje različnih bolezni pri odraslih, med drugim tudi za srčne bolezni in povišan krvni tlak.
Hemangiol at a dose of 3 mg/kg per day (given as two separate doses of 1.5 mg/kg) given for 6 months was shown to be more effective than placebo. 
Zdravilo Hemangiol v odmerku 3 mg/kg na dan (ki so ga dajali z dvema ločenima odmerkoma po 1,5 mg/kg) je bilo po 6 mesecih dajanja učinkovitejše od placeba.
Why is Hemangiol approved? 
Zakaj je bilo zdravilo Hemangiol odobreno?
Based on this plan, safety information has been included in the summary of product characteristics and the package leaflet for Hemangiol, including the appropriate precautions to be followed by healthcare professionals and patients. 
V skladu s tem načrtom so bile v povzetek glavnih značilnosti zdravila Hemangiol in navodilo za njegovo uporabo vključene informacije o varnosti, vključno s previdnostnimi ukrepi, ki jih morajo upoštevati zdravstveni delavci in bolniki.
For practical information about using Hemangiol, patients should read the package leaflet or contact their doctor or pharmacist. 
Za praktične informacije o uporabi zdravila Hemangiol naj bolniki preberejo navodilo za uporabo ali se posvetujejo z zdravnikom ali farmacevtom.
It is used to treat children with proliferating infantile haemangioma, which are benign tumours (abnormal non-cancerous growths) of blood vessels. 
Uporablja se za zdravljenje otrok s hitro rastočimi infantilnimi hemangiomi, ki so benigni tumorji (nenormalne nerakave tvorbe) krvnih žil.
Treatment should be started in appropriate facilities in case serious side effects develop. 
Uvede se lahko le v ustreznih zdravstvenih ustanovah, saj se lahko pojavijo resni neželeni učinki.
For the full list of all side effects reported with Hemangiol, see the package leaflet. 
Za celoten seznam neželenih učinkov, o katerih so poročali pri uporabi zdravila Hemangiol, glejte navodilo za uporabo.
In around 60% (61 out of 101) of children treated with the most effective dose of Hemangiol (3 mg/kg/day for 6 months), haemangiomas disappeared completely or almost completely compared with around 4% (2 out of 55) in children who received placebo. 
Hemangiomi so popolnoma ali skoraj popolnoma izginili pri približno 60 % (61 od 101) otrok, zdravljenih z najučinkovitejšim odmerkom zdravila Hemangiol (3 mg/kg/dan v obdobju 6 mesecev), v primerjavi s približno 4 % (2 od 55) otrok, ki so prejemali placebo.
It is not intended to provide practical advice on how to use Hemangiol. 
Povzetek ni namenjen zagotavljanju praktičnih nasvetov o njegovi uporabi.
The dose is given to the baby during or immediately after a feed using the oral syringe provided. 
Zdravilo se dojenčku odmerja s priloženo brizgo za peroralno dajanje med hranjenjem ali takoj po njem.
Although it is not exactly known how Hemangiol works in proliferative infantile haemangioma, it is thought to do so by several mechanisms including narrowing the blood vessels and so decreasing blood supply to the haemangioma, blocking the formation of new blood vessels in the growth, triggering cell death of the abnormal blood vessel cells and blocking the effect of certain proteins (called VEGF and bFGF), which are important for the growth of blood vessels. 
Med drugim zoži krvne žile in tako zmanjša oskrbo hemangioma s krvjo, prepreči nastajanje novih krvnih žil v tvorbi, povzroči odmiranje nenormalnih celic krvnih žil in prepreči učinek določenih beljakovin (imenovanih VEGF in bFGF), ki imajo pomembno vlogo pri rasti krvnih žil.
Hemangiol can only be obtained with a prescription. 
Izdaja zdravila Hemangiol je le na recept.
How does Hemangiol work? 
Kako zdravilo Hemangiol deluje?
How is Hemangiol used? 
Kako se zdravilo Hemangiol uporablja?
Hemangiol is available as a solution to be taken by mouth. 
Zdravilo Hemangiol je na voljo v obliki raztopine, ki se daje peroralno.
Adopted at the 9-12 April 2018 PRAC 
Sprejeto na seji odbora PRAC od 9. do 12. aprila 2018
Therefore, if you are breastfeeding, your child should receive vitamin K1. 
Če dojite, mora vaš otrok prejemati vitamin K1.
Phenprocoumon is contraindicated during pregnancy (see section 4.3). 
Uporaba fenprokumona med nosečnostjo je kontraindicirana (glejte poglavje 4.3).
This means taking <...> during pregnancy can lead to malformations and even death of your unborn child. 
To pomeni, da lahko jemanje zdravila <…> med nosečnostjo povzroči malformacije in celo smrt nerojenega otroka.
You must not use <…> when you are pregnant, as it passes from mother to child. 
Med nosečnostjo ne smete uporabljati zdravila <…>, saj prehaja z matere na otroka.
Table 2: Tabulated summary of adverse reactions 
Preglednica 2: Tabelarični pregled neželenih učinkov
There is also a risk of bleeding in the foetus (foetal hemorrhage). 
Obstaja tudi tveganje za krvavitev pri plodu (fetalno krvavitev).
Women of childbearing age who are taking <…> have to use effective contraceptive measures during treatment and should continue for 3 months after the last dose. 
Ženske v rodni dobi, ki jemljejo zdravilo <…>, morajo med zdravljenjem in tri mesece po zadnjem odmerku uporabljati učinkovito kontracepcijo.
In cases of exposure to phenprocoumon during second and third trimester of pregnancy, the foetus is at an increased risk of intrauterine or parturitional (cerebral) hemorrhage due to foetal anticoagulation. 
V primerih izpostavljenosti fenprokumonu v drugem in tretjem trimesečju nosečnosti je pri plodu povečano tveganje za intrauterino ali obporodno (možgansko) krvavitev zaradi fetalne antikoagulacije.
There is epidemiological evidence suggesting that the risk of birth defects and foetal death increases with the increasing duration of exposure to phenprocoumon during the first trimester of pregnancy, with a steep increase of the rate of major birth defects when phenprocoumon treatment is continued beyond the 5th gestational week. 
Epidemiološki dokazi kažejo, da se tveganje za prirojene napake in smrt plodu povečuje s trajanjem izpostavljenosti fenprokumonu v prvem trimesečju nosečnosti, z izrazitim povečanjem deleža resnih prirojenih napak, če se zdravljenje s fenprokumonom nadaljuje še po petem gestacijskem tednu.
Women of childbearing potential planning a pregnancy should be switched to a safer alternative treatment prior to pregnancy. 
Ženske v rodni dobi, ki načrtujejo nosečnost, morajo pred zanositvijo preiti na varnejše drugo zdravljenje.
Lapatinib - Pulmonary hypertension (EPITT no 19089) 
Lapatinib - Pljučna hipertenzija (EPITT št. 19089)
If you wish to get pregnant or if you already became pregnant while taking this medicine, talk to your doctor immediately as you should be switched to a safer alternative treatment (e.g. heparin) if you are planning a pregnancy or immediately after recognition of pregnancy. 
Če želite med jemanjem tega zdravila zanositi ali ste že zanosili, se nemudoma pogovorite z zdravnikom, saj morate v primeru, da načrtujete nosečnost, ali takoj potem, ko ugotovite, da ste zanosili, preiti na varnejše drugo zdravljenje (npr. heparin).
If the patient becomes pregnant while taking <…>, the patient should immediately be switched to a safer alternative treatment (e.g. heparin) and close follow-up including level II ultrasound should be recommended. 
Če bolnica med jemanjem zdravila <…> zanosi, mora nemudoma preiti na varnejše drugo zdravljenje (npr. heparin), pri čemer se priporoča skrbno spremljanje, vključno z ultrazvočno preiskavo II.
In nursing mothers, the active ingredient passes into the breast milk, though in such small amounts that no adverse reactions are likely to occur in the infant. 
Učinkovina pri doječih materah prehaja v mleko, vendar v tako majhnih količinah, da se pri otroku verjetno ne bo pojavil noben neželeni učinek.
Frequency not known: pulmonary arterial hypertension (increased blood pressure in the arteries (blood vessels) of the lungs) 
Neznana pogostnost: Pljučna arterijska hipertenzija (zvišan krvni tlak v pljučnih arterijah (krvnih žilah v pljučih))
Phenprocoumon - Risk of birth defects and foetal loss following first trimester exposure as a function of the time of withdrawal (EPITT no 18902) 
Fenprokumon - tveganje za prirojene napake in splav po izpostavljenosti v prvem trimesečju v odvisnosti od časa odtegnitve (EPITT št. 18902)
Common: pneumonia (including bacterial, viral, and fungal), upper respiratory tract infection/inflammation, herpes virus infection (including cytomegalovirus-CMV), enterocolitis infection, sepsis (including uncommon cases with fatal outcomes) 
Pogosti: pljučnica (vključno z bakterijsko, virusno in mikotično pljučnico), okužba/vnetje zgornjih dihal, okužba z virusi herpesa (vključno s citomegalovirusom - CMV), enterokolitis, sepsa (tudi občasni primeri s smrtnimi izidi)
Amitriptyline - Dry eye (EPITT no 19173) 
Amitriptilin - suhe oči (EPITT št. 19173)
Undesirable effects Tabulated list of adverse reactions Skin and subcutaneous tissue disorders Frequency ‘not known': Angioedema, urticaria 
Tabelarični povzetek neželenih učinkov Bolezni kože in podkožja Neznana pogostnost: Angioedem, urtikarija
As a precaution, however, prophylaxis involving the administration of vitamin K1 to the infant concerned is recommended. 
Kot previdnostni ukrep se pri dojenčkih priporoča profilaksa z dajanjem vitamina K1.
If you are breastfeeding, <…> passes into the breast milk, though in such small amounts that no adverse reactions are likely to occur to your child. 
Če dojite, zdravilo <…> prehaja v mleko, vendar v tako majhnih količinah, da se pri otroku verjetno ne bo pojavil noben neželeni učinek.
Frequency not known: pulmonary arterial hypertension 
Neznana pogostnost: Pljučna arterijska hipertenzija Navodilo za uporabo
Possible side effects Frequency ‘not known': Dry eyes 
Možni neželeni učinki Neznana pogostnost: Suhe oči
Common side effects (may affect up to 1 in 10 people) Infections: pneumonia, herpes virus infection (including cytomegalovirus-CMV), upper respiratory tract infection, serious infection of the blood or tissues (including uncommon cases with fatal outcomes) 
Pogosti neželeni učinki (pojavijo se lahko pri največ 1 od 10 bolnikov) Okužbe: pljučnica, okužba z virusi herpesa (vključno s citomegalovirusom - CMV), okužba zgornjih dihal in resna okužba krvi ali tkiv (tudi občasni primeri s smrtnimi izidi)
In humans phenprocoumon crosses the placental barrier. 
Fenprokumon pri ljudeh prehaja skozi posteljico.
Based on human experience phenprocoumon may cause birth defects and foetal death when administered during pregnancy. 
Na podlagi izkušenj pri ljudeh lahko dajanje fenprokumona med nosečnostjo povzroči prirojene napake in smrt plodu.
You must prevent becoming pregnant by taking effective contraceptive measures during therapy with <…> and in the period of 3 months after completion of the treatment with <…> due to the increased risk of foetal malformations. 
Med zdravljenjem z zdravilom <…> in tri mesece po končanem zdravljenju z zdravilom <…> morate zaradi povečanega tveganja za malformacije pri plodu uporabljati učinkovito kontracepcijo, da preprečite zanositev.
Not known: frequency cannot be estimated from available data 
Neznana pogostnost: pogostnosti iz razpoložljivih podatkov ni mogoče oceniti otekanje obraza, ustnic, jezika ali žrela koprivnica
Summary of product characteristics 4.8. 
4.8 Neželeni učinki
Vortioxetine - Angioedema and urticaria (EPITT no 
Vortioksetin - angioedem in urtikarija (EPITT št. 19099)
Dasatinib - Cytomegalovirus (CMV) reactivation (EPITT no 
Dasatinib - reaktivacija citomegalovirusa (CMV) (EPITT št. 19111)
What you need to know before you take <…> 
Kaj morate vedeti, preden boste vzeli zdravilo <…> Nosečnost, dojenje in plodnost
Hives 
ravni.
Undesirable effects Under SOC ‘Eye disorders' Frequency ‘not known': Dry eye 
Pod organskim sistemom „Očesne bolezni“ Neznana pogostnost: Suhe oči Navodilo za uporabo 4.
These reactions resolve over an average of 4 days. 
Tovrstne reakcije minejo povprečno v 4 dneh.
Reconstitute the vaccine as described above. 
Rekonstituirajte cepivo, kot je opisano zgoraj.
The cough may last for one to two months or longer. 
Kašelj lahko traja en do dva meseca ali dlje.
Each individual pack cannot be sold separately 
Posameznega pakiranja ni možno prodajati ločeno.
Date of latest renewal: 31 August 2010 
Datum zadnjega podaljšanja: 31. avgust 2010
This is a normal observation. 
To opažanje je normalno.
DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION Date of first authorisation: 23 October 2000 
DATUM PRIDOBITVE/PODALJŠANJA DOVOLJENJA ZA PROMET Datum prve odobritve: 23. oktober 2000
Other tests should be performed in order to confirm Hib infection during this period. 
Za potrditev okužbe s Hib v tem obdobju je treba uporabiti druge teste.
Stability data indicate that the vaccine components are stable at temperatures up to 25°C for 72 hours. 
Stabilnostni podatki kažejo, da so komponente cepiva stabilne 72 ur pri temperaturah do 25 °C.
However, sometimes it can be very serious and cause permanent damage or even death. 
Včasih pa je lahko zelo resna in povzroči trajne poškodbe ali celo smrt.
The clinical relevance of these observations remains unknown. 
Klinični pomen tega opažanja ni znan.
1adsorbed on Al(OH)3 
1adsorbiran na Al(OH)3
They usually happen within 2 to 3 days after vaccination. 
Navadno se pojavijo v dveh do treh dneh po cepljenju.
• a sudden drop in blood pressure and loss of consciousness. 
• nenaden padec krvnega tlaka in izguba zavesti.
Tell your doctor if your child has had an allergic reaction to these ingredients. 
Zdravniku povejte, če je vaš otrok imel alergično reakcijo na ti sestavini.
This will protect your child against these diseases. 
To bo vašega otroka zaščitilo pred temi boleznimi.
• if your child has an undiagnosed or progressive disease of the brain or epilepsy which is not controlled. 
• če ima vaš otrok nediagnosticirano ali napredujočo bolezen možganov ali epilepsijo, ki ni nadzorovana.
Freezing destroys the vaccine. 
Zamrzovanje cepivo uniči.
Tell your doctor or pharmacist if your child is taking, has recently taken, might take any other medicines or has recently received any other vaccine. 
Obvestite zdravnika ali farmacevta, če vaš otrok jemlje, je pred kratkim jemal ali pa bo morda začel jemati katero koli drugo zdravilo ali je pred kratkim prejel katero koli drugo cepivo.
Household contact study (prospective blinded) 
Študija kontaktov v gospodinjstvu (prospektivna, slepa)
The arms or legs affected by the disease may be painfully twisted (deformed). 
Noge in roke, ki jih bolezen prizadene, so lahko boleče ukrivljene (deformirane).
This includes the muscles needed for breathing and walking. 
To lahko vključuje tudi mišice potrebne za dihanje in hojo.
• The vaccine cannot cause the diseases that it protects your child from. 
• Cepivo ne more povzročiti bolezni, pred katerimi ščiti vašega otroka.
• Do not use this vaccine after the expiry date which is stated on the carton. 
• Tega cepiva ne smete uporabljati po datumu izteka roka uporabnosti, ki je naveden na škatli.
If not, your child may not be fully protected against the diseases. 
V nasprotnem primeru, je možno, da vaš otrok ni popolnoma zaščiten pred boleznimi.
Children at 7-8 years of age 
Otroci stari 7-8 let
Evaluation of pharmacokinetic properties is not required for vaccines. 
Vrednotenje farmakokinetičnih lastnosti za cepiva ni zahtevano.
These data are intended to guide healthcare professionals in case of temporary temperature excursion only. 
Ti podatki so namenjeni kot navodilo zdravstvenim delavcem le v primeru krajših temperaturnih odstopov.
Frequencies per dose are defined as follows: 
Pogostnost na odmerek je definirana kot sledi: Zelo pogosti:
4propagated in VERO cells 
4namnožen v celicah VERO
A minor infection such as a cold should not be a problem, but talk to your doctor first. 
Blažje okužbe, kot je na primer prehlad, ne bi smele biti težava, vendar se pred cepljenjem vseeno pogovorite s svojim zdravnikom.
• if your child has a severe infection with a high temperature (over 38°C). 
• če ima hudo okužbo z zvišano telesno temperaturo (nad 38 °C).
• swelling of the eyes and face 
• otekle oči in obraz,
As the benefit of the vaccination is high in these infants, vaccination should not be withheld or delayed. 
Ker je korist cepljenja teh dojenčkov velika, cepljenja ne bi smeli odložiti ali ga izpustiti.
For pertussis there is no serological correlate of protection. 
Za oslovski kašelj ni serološkega korelata zaščite.
• Safety in preterm infants: 
• Varnost pri nedonošenčkih:
Hepatitis B immunological memory was confirmed in children 4 to 15 years of age. 
Imunološki spomin za hepatitis B je bil potrjen pri otrocih od 4. do 15. leta starosti.
• Store in a refrigerator (2°C - 8°C). 
• Shranjujte v hladilniku (2 °C - 8 °C).
Polio is often only a mild illness. 
Otroška paraliza je pogosto le blaga bolezen.
not less than 40 International Units (IU) 
ne manj kot 40 internacionalnih enot (i.e.)
• As with all vaccines, Infanrix hexa may not fully protect all children who are vaccinated. 
• Tako kot velja za vsa cepiva, cepivo Infanrix Hexa morda ne bo popolnoma zaščitilo vseh cepljenih otrok.
These signs usually start very soon after the injection has been given. 
Ti znaki se navadno pojavijo kmalu po prejetju odmerka.
The vaccine may contain traces of formaldehyde, neomycin and polymyxin which are used during the manufacturing process (see section 4.3). 
Cepivo lahko vsebuje sledi formaldehida, neomicina in polimiksina, ki se uporabljajo med proizvodnim procesom (glejte poglavje 4.3).
BATCH NUMBER LOT: 
ŠTEVILKA SERIJE Lot:
2 Adverse reactions from spontaneous reporting. 
2 Neželeni učinki iz spontanih poročil.
These reactions were mostly moderate (less than or equal to 39°C) and transient (see sections 4.5 and 4.8). 
Večinoma so bile te reakcije zmerne (39 °C ali manj) in prehodne (glejte poglavji 4.5 in 4.8).
The signs may include: 
Znaki so lahko:
not less than 30 International Units (IU) 
ne manj kot 30 internacionalnih enot (i.e.)
• You will be told by the doctor or nurse when your child should come back for their next injections. 
• Zdravnik ali sestra vam bosta naročila, kdaj mora vaš otrok priti po naslednje odmerke.
≥ 40 IU 
≥ 40 i.e.
The results of these clinical studies are summarised in the tables below. 
Spodaj so v preglednicah povzeti rezultati kliničnih študij.
The immune responses were unaffected. 
Imunski odzivi so bili neprizadeti.
If your child has an allergic reaction, see your doctor straight away. 
Če ima vaš otrok alergijsko reakcijo, nemudoma obiščite svojega zdravnika.
• Tetanus: tetanus bacteria enter the body through cuts, scratches or wounds in the skin. 
• Tetanus: bakterije tetanusa pridejo v telo skozi vreznine, praske ali rane na koži.
Children at 4-5 years of age 
Otroci stari 4-5 let
• The vaccine should never be given into a blood vessel or into the skin. 
• Cepiva se ne sme nikoli dati v žilo ali pod kožo.
0.32 milligrams Al3+ 
0,32 miligramov Al3+
SPECIAL PRECAUTIONS FOR DISPOSAL OF UNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS DERIVED FROM SUCH MEDICINAL PRODUCTS, IF APPROPRIATE 
POSEBNI VARNOSTNI UKREPI ZA ODSTRANJEVANJE NEUPORABNIH ZDRAVIL ALI IZ NJIH NASTALIH ODPADNIH SNOVI, KADAR SO POTREBNI
Talk to a doctor straight away if they happen after leaving the doctor's surgery. 
Nemudoma se posvetujte z zdravnikom, če se pojavijo po odhodu iz ambulante.
• Diphtheria: a serious bacterial infection that mainly affects the airways and sometimes the skin. 
• Davica: resna bakterijska okužba, ki v glavnem prizadene dihalne poti in občasno kožo.
Infanrix hexa is a vaccine used to protect your child against six diseases: 
Infanrix hexa je cepivo, ki vašega otroka lahko zaščiti pred šestimi boleznimi:
• difficulty in breathing or swallowing 
• težave pri dihanju ali požiranju,
Collapse or shock-like state (hypotonichyporesponsive episode)2 
Redki kolaps ali šoku podobno stanje (hipotonična-hiporesponzivna epizoda)2
• times when they lose consciousness or have a lack of awareness 
• obdobja, ko otrok izgubi zavest ali se ne zaveda,
Very common Crying abnormal, irritability, restlessness Common 
Zelo pogosti neobičajen jok, razdražljivost,
Pharmaco-therapeutic group: Bacterial and viral vaccines combined, ATC code: J07CA09 
Farmakoterapevtska skupina: Kombinacija bakterijskih in virusnih cepiv, oznaka ATC: J07CA09 Imunogenost
The reconstituted vaccine appears as a slightly more cloudy suspension than the liquid component alone. 
Rekonstituirano cepivo je na videz bolj motna suspenzija kot sama tekoča komponenta.
At the end of this period Infanrix hexa should be used or discarded. 
Ob koncu tega obdobja morate cepivo Infanrix hexa uporabiti ali zavreči.
The vaccine is reconstituted by adding the entire contents of the pre-filled syringe to the vial containing the powder. 
Cepivo rekonstituiramo z dodajanjem celotne vsebine napolnjene injekcijske brizge viali, ki vsebuje prašek.
Very rare (these may happen with up to 1 in 10,000 doses of the vaccine): itching (dermatitis). 
Zelo redki (pojavijo se lahko pri največ 1 od 10.000 odmerkov cepiva): srbenje (dermatitis).
This can lead to serious problems such as mental slowness (retardation), cerebral palsy, deafness, epilepsy or partial blindness. 
To lahko vodi do resnih težav, kot so miselna počasnost (zaostalost), cerebralna paraliza, gluhost, epilepsija ali delna slepota.
Clinical data generated with paracetamol and ibuprofen suggest that the prophylactic use of paracetamol might reduce the fever rate, while prophylactic use of ibuprofen showed a limited effect in reducing fever rate. 
Klinični podatki pridobljeni s paracetamolom in ibuprofenom kažejo, da profilaktično uporabljeni paracetamol lahko zniža zvišano telesno temperaturo, medtem ko profilaktična uporaba ibuprofena kaže omejen učinek na znižanje zvišane telesne temperature.
Antipyretic treatment should be initiated according to local treatment guidelines. 
Antipiretično zdravljenje naj poteka skladno z lokalnimi smernicami.
Read all of this leaflet carefully before your child receives this vaccine because it contains important information for you. 
Preden vaš otrok dobi to cepivo, natančno preberite navodilo, ker vsebuje za vas pomembne podatke!
Primary vaccination Booster vaccination 
Primarno cepljenje Obnovitveno cepljenje
For any information about this medicine, please contact the local representative of the Marketing Authorisation Holder: 
Za vse morebitne nadaljnje informacije o tem cepivu se lahko obrnete na predstavništvo imetnika dovoljenja za promet s cepivom:
≥ 30 IU 
≥ 30 i.e.
Vaccination should be preceded by a review of the medical history (especially with regard to previous vaccination and possible occurrence of undesirable events) and a clinical examination. 
Pred cepljenjem moramo preučiti anamnezo otroka (s poudarkom na predhodnih cepljenjih in morebitnih neželenih učinkih) in opraviti klinični pregled.
The immunogenicity of Infanrix hexa has been evaluated in clinical studies from 6 weeks of age. 
Imunogenost cepiva Infanrix hexa so ovrednotili v kliničnih študijah od 6 tednov starosti.
The mixed appearance is a white, slightly milky liquid. 
Mešanica je bela, rahlo mlečna tekočina.
This can help to lower some of the side effects (febrile reactions) of Infanrix hexa. 
To lahko pomaga zmanjšati nekatere neželene učinke (vročinske reakcije) cepiva Infanrix hexa.
See also section 4 Possible side effects. 
Glejte tudi poglavje 4 Možni neželeni učinki;
0.5 milligrams Al3+ 
0,5 miligramov Al3+
If either is observed, discard the vaccine. 
Če opazite karkoli od tega, cepivo zavrzite.
The safety and efficacy of Infanrix hexa in children over 36 months of age have not been established. 
Varnost in učinkovitost cepiva Infanrix hexa pri otrocih, starejših od 36 mesecev, ni bila dokazana.